Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Nucleic Acids Research|November 7, 2018
ChEMBL: towards direct deposition of bioassay dataDavid Mendez, Anna Gaulton, A Patrícia Bento, et al.Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.Biorxiv : the Preprint Server for Biology|April 1, 2024
Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in CellsPatrick J Brennan, Rebecca E Saunders, Mary Spanou, et al.Nature Communications|July 4, 2024
A data science roadmap for open science organizations engaged in early-stage drug discoveryKristina Edfeldt, Aled M Edwards, Ola Engkvist, et al.Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitorsNigel S Watson, David Brown, Matthew Campbell, et al.Cell Chemical Biology|December 26, 2017
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target InteractionsJing Tang, Zia-Ur-Rehman Tanoli, Balaguru Ravikumar, et al.Nucleic Acids Research|November 28, 2024
EMBL's European Bioinformatics Institute (EMBL-EBI) in 2024Matthew Thakur, Catherine Brooksbank, Robert D Finn, et al.Nature|August 6, 2010
Type IIA topoisomerase inhibition by a new class of antibacterial agentsBenjamin D Bax, Pan F Chan, Drake S Eggleston, et al.ACS Chemical Biology|November 2, 2025
Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in CellsPatrick J Brennan, Rebecca E Saunders, Mary Spanou, et al.Molecular Systems Biology|July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screensEmanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.Pageof 8